Your selections:
Characterizing changes in the orexin system in models of neuropsychiatric disease
Insights for developing pharamacological treatments for psychostimulant replapse targeting hypothalamic peptide systems
- James, Morgan H., Yeoh, Jiann W., Graham, Brett A., Dayas, Christopher V.
Exercise reverses the effects of early life stress on orexin cell reactivity in male but not female rats
- James, Morgan H., Campbell, Erin J., Walker, Frederick R., Smith, Doug W., Richardson, Heather N., Hodgson, Deborah M., Dayas, Christopher V.
Characterising how chronic stress and natural rewards impact lateral hypothalamic circuitry
Complex regulatory interactions control CRH gene expression
- Nicholson, Richard C., King, Bruce R., Smith, Roger
Excitatory amino acid receptors mediate asymmetry and lateralization in the descending cardiovascular pathways from the dorsomedial hypothalamus
- Xavier, Carlos Henrique, Ianzer, Danielle, Lima, Augusto Martins, Marins, Fernanda Ribeiro, Pedrino, Gustavo Rodrigues, Vaz, Gisele, Menezes, Gustavo Batista, Nalivaiko, Eugene, Fontes, Marco Antônio Peliky
Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
- Yeoh, Jiann Wei, Campbell, Erin J., James, Morgan H., Graham, Brett A., Dayas, Christopher V.
Cocaine potentiates excitatory drive in the perifornical/lateral hypothalamus
- Yeoh, Jiann Wei, James, Morgan H., Jobling, Philip, Bains, Jaideep S., Graham, Brett A., Dayas, Christopher V.
- Zouikr, Ihssane, Tadros, Melissa A., Barouei, Javad, Beagley, Kenneth W., Clifton, Vicki L., Callister, Robert J., Hodgson, Deborah M.
Are you sure you would like to clear your session, including search history and login status?